Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
LA JOLLA PHARMACEUTICAL CO
| Metric | LA JOLLA PHARMACEUTICAL CO Healthcare |
|---|---|
| Quality Score | 68 / 100 |
| Revenue (latest) | $76M |
| Net income (latest) | $20M |
| Operating margin | 28.8% |
| Net margin | 26.0% |
| Return on equity | −29.5% |
| Return on assets | 19.4% |
| Return on capital (ROCE) | 26.1% |
| Debt / equity | — |
| Revenue growth (YoY) | 126.6% |
| Altman Z″ (distress) | -29.79 |
| Accruals / assets | −8.5% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.